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Background. In this study we evaluate published and personal experience of Endovascular Repair (EVAR) of penetrating
atherosclerotic ulcers (PAU).
Patients and method. In 12 patients (mean 74 years, 58e87 years) PAU was diagnosed with computer tomography (CT).
Symptomatic ulcers were treated by vascular surgeons using stentgrafts via a femoral access route. Patients were followed
up clinically and with CT for an average of 849 days (186e1968 days).
Results. 11 patients had severe acute thoracic pain, one patient presented with hemoptysis. CT showed well outlined ulcer,
intramural hematoma, and contrast enhancement of the aortic wall (n¼ 12), pseudoaneurysm (n¼ 11), intimal calcifica-
tion adjoining the ulcer (n¼ 10), pleural (n¼ 9) and mediastinal fluid (n¼ 4). Mean duration of surgery was 68 min
(32e120 min). Primary technical success was achieved in all patients. There was no perioperative complications except
one acute hemorrhage from an intercostal artery and one iliac dissection. 3 months after stentgraft application owing to
a severe stenosis of the right common femoral artery, an iliofemoral bypass was performed in one patient. All patients
were free of symptoms after the procedure. There was incomplete sealing of PAU in 2 of 12 patients, but no re-intervention
was needed. All patients were alive during follow-up.
Conclusion. Symptomatic PAU is a potentially fatal lesion. Considering the low morbidity and mortality of EVAR, this
option might be first choice.
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Penetrating atherosclerotic ulcer (PAU) of the aorta
was first described in 19341 and further characterized
by Stanson et al.2 in 1984. In 2001, a new classification
for acute thoracic aortic syndrome was presented by
an aortic dissection task force of the European Society
of Cardiology. The dissections are distinguished
according to their effect on the aortic wall.3 PAU is
defined as ulceration that penetrates through the elas-
tic lamina into the tunica media and that is associated
with a variable hematoma volume within the aortic
wall.2,4 It is a process involving the total wall of the
aorta. However, it must be clearly distinguished
from the entities of aneurysm, intramural hemorrhage
and classical aortic dissection.4e8
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develops in patients with advanced atherosclerosis.
At this point, the lesions are usually asymptomatic
and confined to the intima.5 In the next stage, the
lesion enlarges, forming a deep atheromatous ulcer
which penetrates through the elastic lamina into the
tunica media. The hematoma can spread along the
tunica media which can lead to dissection of the aorta.
As a rule, this gives rise to both a false and a true
lumen without re-entry of the false lumen. This ap-
pears to be caused by the pronounced atherosclerosis
which prevents the development of re-entry.9
In contrast to classical dissection, which often oc-
curs in patients about 50 years old, PAU is mostly
manifested in patients over 70 years. Acute thoracic
symptoms may be absent and trivial trauma may
lead to lethal rupture of the aorta. Development of
pseudoaneurysms and thromboemboli is typical. If
erosion of vasa vasorum of the aortic media by the
central ulcer occurs painful intramural hemorrhage
may result. In contrast to intramural hematoma, this
bleeding is mostly localized and rarely leads torved.
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by acute bleeding from ruptured vasa vasorum of
the aortic media. However, it shows no communica-
tion with the true lumen and can extend over the en-
tire aorta. The bleeding arises suddenly and causes
very severe pain.10
The penetrating aortic ulcer can develop further in
three different ways: formation of an intramural hema-
toma, development of a false aortic aneurysm or rup-
ture of the aortic wall with extravasation of blood.
The probability of rupture is reported to be up to 40%.11
Symptomatic PAU of the thoracic aorta must be
clearly distinguished from asymptomatic PAU which
is diagnosed by chance and does not require urgent
therapy. This paper presents the clinical data of 12 pa-
tients with symptomatic PAU accompanied by violent
pain (acute thoracic aortic syndrome), the primary
diagnosis of PAU with CT, the surgical endovascular
repair of PAU and the follow up of these patients by
clinical examination and by CT.
Patients and Methods
From May 2001 to March 2006, 12 patients were ad-
mitted to the hospital as emergency cases because of
severe thoracic pain and the clinical diagnosis of a dis-
section of the thoracic aorta. A CT of the whole aorta
was performed in order to establish the diagnosis of
PAU in all patients. All these patients received endo-
vascular treatment for symptomatic PAU. No conven-
tional surgical treatments for PAU were given in the
study period.
Preoperative imaging evaluation
A three-phase multidetector-row CT of the whole
aorta was acquired. All images were evaluated at
a digital reading work station (MX View, Philips Med-
izin Systeme, Hamburg/Germany) and reconstructed
in multiplanar reformations in order to assess feasibil-
ity for endovascular treatment as described several
times before.12e16 As CT enables the access route of
the stentgraft to be clarified, a digital subtraction angio-
graphy (DSA) of the iliac arteries and the aorta was
not required.
Surgical technique
All operations were performed under general anaes-
thesia in the surgical operating room under fluoros-
copy control by a C-arm image intensifier (OEC 9600
Vascular, GE Medical Systems Germany) as Orend
described before in this journal.13 In brief Stentgraftswere introduced over a superstiff Amplatz guide
wire (Boston Scientific, Ratingen, Germany). Stent-
graft deployment was performed in respiratory arrest
but without pharmacologically induced hypotension
or cardiac arrest. When the stentgrafts had been
deployed at the preset marker points a completion
angiogram confirmed exact position, total exclusion
and coverage of the aortic lesion.12e15
In 11 patients, the ulcer was treated with one stent-
graft (8Gore TAG, 1 Endofit, 2Cook Zenith).
One patient needed two stentgrafts (1Gore TAG,
1Medtronic Talent). As in this case the needed di-
ameters were not at hand from one company, two
different devices were chosen. The average length
of the stent-graft was 132 mm (120e220 mm). The di-
ameter of the stent-graft varied from 34 mme40 mm.
Special maneuvers to lower blood pressure or to in-
duce cardiac arrest were not required in a single
case. Ballooning of the stentgraft was dispensed
with in all cases because of the special pathology
of the aortic rupture.
Postoperative course
The patients were looked after on an intermediate care
ward for one day after the operation. Afterwards, they
were transferred to a regularward. In the first year after
the operation, the patients were called to attend an out-
patient follow-up examination every six months. Be-
sides the physical examination, a CT of the aorta was
taken. After the first year, further follow-up examina-
tions are envisaged at intervals of one year.
Results
Patients and clinical findings
12 patients (3 women, 9 men) with an average age of
74 years (range 58 to 87 years) were included in this
retrospective analysis. At the time of hospitalization,
11 patients complained of severe acute thoracic pain,
1 patient additionally had hemoptysis.
A risk factor in all patients except for one case was
vascular hypertension that had been present for many
years. Four patients were active smokers. Three pa-
tients had elevated creatinine levels (AG: 164 mmol/l;
AE: 186 mmol/l; HP 174 mmol/l). Two patients were
diabetic (type 2).
Three patients had an infrarenal aneurysm of the
abdominal aorta in their history, which were under
surveillance. One patient had suffered a myocardial
infarction six months previously and another patient
had a stroke in the past.Eur J Vasc Endovasc Surg Vol 34, July 2007
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logists (ASA), one patient was categorized in ASA
class II, seven patients were categorized in ASA class
III and four patients in ASA class IV.
Imaging features (Table 1, Fig. 1)
In all patients, the well outlined ulcer in the aortic
wall was detectable and was located in the descend-
ing aorta (4 proximal third, 5middle third,
3 distal third). Five patients had more than one
PAU of the thoracic aorta without relation to the intra-
mural hematoma or without signs of acute bleeding
or perforation. The size of the symptomatic PAU
was up to 40 mm in cranio-caudal extension. In all pa-
tients, CT demonstrated an intramural hematoma
with a contrast enhancement of the peripheral aortic
wall. In one patient, there were small gas bubble in
the hematoma, so that an infection was suspected.
In 11 cases, the intramural hematoma led to a pseudo-
aneurysm in the aortic segment of PAU. In 10 patients,
intimal calcification adjoining the ulcer was seen on
CT. Pleural effusion was frequent (n¼ 9) whereas
mediastinal bleeding was rare in our patients (n¼ 4).
Surgical procedure
The stentgraft was implanted without any intraopera-
tive complication and thus primary technical success
was achieved in all patients. In one patient, 2 stent-
grafts were introduced because of multiple PAU
with irregular rim so that multiple PAU were regar-
ded as responsible for intramural hemorrhage. Be-
cause of the extensive hemothorax in one patient,
Table 1. Typical imaging features in penetrating atherosclerotic
ulcer (PAU) as visualized by CT and its frequency in the whole
patient collective (n[ 12)
CT findings Number of patients
n (
P¼ 12)
well outlined ulcer 12
mean size [mm]
cranio-caudal 20.0 mm (11e40 mm)
length of ulcer crater 16.7 mm (8e36 mm)
depth of ulcus 13.0 mm (6e27 mm)
hematoma in the aortic wall 12
contrast enhancement of
peripheral aortic wall
12
Pseudoaneurysm 11
intimal calcification
adjoining the ulcer
10
pleural effusion 9
unilateral 6
bilateral 3
mediastinal fluid 4
Shown are also the mean sizes of ulcer in cranio-caudal plane, the
length of ulcus crater (axial diameter) and the depth of ulcus.Eur J Vasc Endovasc Surg Vol 34, July 2007we expanded this operation and performed addition-
ally a thoracotomy for removal the hematoma. After
stentgraft deployment, one patient had a dissection
of the external iliac artery caused by the intervention,
so that an iliofemoral polyester graft was inserted. We
observed one perioperative complication: A few
hours after stentgraft implantation, a patient devel-
oped acute bleeding which was hemodynamic rele-
vant, so that a thoracotomy was necessary. After
ligation of a bronchial artery, the postoperative course
was uncomplicated.
In all patients, the thoracic pain vanished after sur-
gery. The average duration of the operation (without
the operation of the iliofemoral bypass and without
the thoracotomy) was 68 minutes (range 32e120 min-
utes). In 4 patients, the left subclavian artery was cov-
ered. This did not give rise to any new symptoms in
the patients as described before.12,16
Patient follow up (Table 2)
The 30-day mortality was 0%. Neither was there any
death in the further course of follow-up (mean 849
days; 186e1968 days). No patient developed tem-
porary neurological deficits, in particular no anterior
spinal syndrome was seen.
At the first follow up a few days after surgical in-
tervention, complete sealing of PAU was observed in
10 of 12 patients (Fig. 2). In two patients, CT showed
an endoleak: The patient with two implanted stent-
grafts developed endoleak in the area of stentgraft-
overlapping-zone, which was not detectable in the
last follow up (after 120 days). Another patient devel-
oped a small endoleak fed by an intercostal artery. This
endoleak was also shown on CT at the last follow up
(after 187 days) without progress or clinical symp-
toms. In the other patients, the radiological follow-up
revealed persistent elimination of the aortic ulcer with-
out dilatation of the aorta in the region of the former
rupture.
In one patient, a perigraft leak (proximal from the
stent) was observed 21 days after the operation; the
patient declined another operation.
Except for this patient, resorption of the intramural
hematoma without development of secondary dissec-
tion was found in all patients during follow-up. Stent-
graft migration or a stentgraft defect could not be
detected. In another patient, a stenosis of the common
femoral artery which was located at the site of the ar-
terial suture in the primary stentgraft implantation
had to be revised three months after the endovascular
operation by performing a femorofemoral polyester
bypass.
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Fig. 1. Native (A), arterial (B) and portavenous phase (C) of contrast enhanced CT (axial slices) from a 61 year old man with
acute severe thoracic pain. In the native phase, there is an acute subintimal hematoma (hyperdense on CT, star). The sur-
rounding tissue shows a contrast enhancement in the venous phase (white arrows). In the arterial and venous phase, there is
a well outlined ulcer in the proximal third of descending aorta (white arrow head). On the ulcer basis, there are typically
two calcifications (black arrow head).Discussion
The prognosis of PAU is considered to be very much
poorer than that of classic aortic dissection.7,17e19
Coady et al.11 reported that the risk of aortic rupture
in patients with penetrating aortic ulcer is 40% com-
pared to patients with type A or type B dissection
where the risk is 7% and 3.6% respectively.
Asymptomatic PAU is normally diagnosed by
chance and does not require therapy. Cook et al.5 rec-
ommend an immediate operation on PAU in symp-
tomatic patients. Pain is specified as one of the main
criteria for surgery, imaging features do not correlate
with need for surgery.2,6,20 Because of these unspecific
symptoms, an early diagnosis is necessary. Cross sec-
tional imaging methods (CT- and MR-angiography)
have replaced digital angiography as the means of
diagnosis.21 CT is the imaging modality of choice
to identify and locate the PAU. Because of the typical
radiological findings on CT such as ulcer crater
combined with intimal calcification or intramural
hemorrhage, this entity can be differentiated fromother causes of acute aortic syndrome such as aortic
dissection and perforated aneurysm. Ganaha et al.22
showed the need to differentiate between an intra-
mural hematoma with and an intramural hematoma
without PAU concerning the outcome of patients. In
this study, increasing pleural effusion, diameter and
depth of PAU were predictors of disease progression.
Willoteaux et al.23 pointed out that in the case of me-
diastinal hemorrhage, the differentiation between
the PAU and ruptured aneurysm can be difficult. CT
examination should be performed multiphasic to de-
tect all these imaging features.24 It is also possible to
identify the ulcer on MRI,7,25 but the examination still
needs more time than CT. Additionally, the compli-
ance of patients with acute symptoms and pain is lim-
ited for MRI examination of the thorax. There are no
randomized studies which compare CT and MRI in
the emergency situation. Furthermore, with CT other
causes of thoracic pain and acute hemoptysis such
as pulmonary embolism can be clarified.
In this study, 11 of 12 patients had severe chest
pain, in one case combined with hemoptysis. InEur J Vasc Endovasc Surg Vol 34, July 2007
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Patient/sex/
age (years)
Follow-up
period (days)
Complications
during follow-up
Primary complete
sealing of PAU
Migration of
the stentgraft
WJ/m/58 1697 Perigraft leak 21 days
after operation
yes no
AG/m/75 1968 no yes no
JG/w/73 1360 no no no
JT/m/61 1328 Femoral Dacron interposition
3 months postoperative
yes no
LG/m/87 1285 no yes no
HO¨/m /71 451 no yes no
AE /m /84 667 New asymptomatic PAU
cranial of the stentgraft
yes no
HP /m /66 206 no yes no
EH /w /83 186 no yes no
MT /m /60 421 no yes no
TA /w /85 415 no no no
EH /m /80 208 no yes no
Given are the initials of patients, sex (m¼male, f¼ female), age (years), the complications during the whole follow up period, the primary
complete sealing of PAU, and migration of the stentgraft.Stanson’s study,2 13 of 16 patients had chest pain,
whereas only four of 18 patients investigated by
Harris et al.26 showed this symptom. Hence, most of
the patients in his study did not have acute aortic syn-
dromes. Moreover, the probability of survival might
be increased if many patients with fortuitous findings
who are asymptomatic are included. In particular,
persistent or recurrent pain, hemodynamic instability
and a rapidly increasing diameter of the aorta are
specified as indications for surgery.27 All patients in
our series showed symptoms of acute thoracic aortic
syndrome.
Emergency surgery of acute aortic syndrome is as-
sociated with substantial morbidity and perioperative
mortality rates between 25% and 50%. These may be
caused by hemorrhage, heart and renal failure or
spinal cord ischemia.11,28,29 The decision to perform
an open operation on the thoracic aorta is madeEur J Vasc Endovasc Surg Vol 34, July 2007more difficult when the patients have serious concom-
itant diseases. All patients in the series we presented
had a raised surgical risk (i.e. primarily ASA class
III and IV, vascular hypertension or elevated creati-
nine levels). It is undeniable that endovascular treat-
ment can be of benefit here.
In this retrospective study, all cases were treated by
vascular surgeons using stentgrafts. As a rule, it is pos-
sible to place the stentgraft via femoral access. Since the
anatomical situation isusually simple, a secondpercuta-
neous access, e.g. via the left subclavian artery or the left
common femoral artery, is not considered to be neces-
sary, but should always be considered in special cases.16
The rate of early endoleakwas in our study 16% (2 of
12 patients). One patient had an intercostal artery feed-
ing the endoleak. In the other one, complete sealing of
PAU was only achievable inserting 2 stentgrafts with
overlapping. The endoleak in our patients wereFig. 2. Venous phase of contrast enhanced CT (A: axial slice, B: sagittal plane) from the same patient (see Fig. 1) 884 days
after operation. Complete sealing of PAU was achieved by stent-graft. No endoleak, migration or stentgraft defect is
detected. The stentgraft adapt to the outershape of aortic wall.
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Study n Complete
sealing of PAU
Mortality
(hospital)
Mortality
follow-up
Follow-up
(months)
Neuro. compl.
Dake et al.29 1998 10 ns 1 ns 22 ns
Murgo et al.31 1998 4 3 1 1 6 1
Brittenden et al.9 1999 2 2 0 0 12 0
Maruyama et al.35 2000 1 1 0 ns ns 0
Quint et al.36 2001 2 2 0 ns ns ns
Haulon et al.37 2002 2 ns 0 0 7.3 0
Pitton et al.38 2002 1 1 0 0 12 0
Schoder et al.39 2002 8 7 0 3 14 1
Kos et al.40 2002 10 9 0 1 9 1
Faries et al.41 2002 1 1 0 0 18 0
Thompson et al.42 2002 1 1 0 0 8.5 0
Rachel et al.43 2002 1 1 0 0 32 0
Czermak et al.32 2002 2 2 0 1 7.2 0
Nienaber et al.44 2002 15 15 0 0 ns 0
Ochi et al.45 2002 1 1 0 0 1 0
Eggebrecht et al.46 2003 10 9 0 0 24.4 0
Crane et al.47 2003 1 1 0 0 12 0
Feld et al.30 2003 1 0 0 0 7 0
Fattori et al.48 2003 6 6 0 ns ns 0
Demers et al.49 2004 26 24 3 3 51 (av) 1
Destrieux-Garnier et al.50 2004 5 4 ns ns 13.5 (av) 0
Schelzig et al.51 2004 6 6 0 0 13 0
Total 116 96/104 (92.3%) 5/111 (4.5%) 9/92 (9.7%) 269.9 (mean 14.9) 4/104 (3.8%)
ns¼ not specified; neuro. compl. ¼ neurologic complications; av¼ average.
Shown are the total number of included patients, complete sealing of PAU (number of patients and %), hospital mortality and follow-up
mortality (number of patients and %), follow-up interval in months (mean time), and the rate of neurologic complications (number of
patients and %).asymptomatic, so that no re-intervention was neces-
sary. However, the incidence of endoleak (incomplete
sealing of PAU) was 7.7% in the published series
(Table 3). Symptomatic or progressive endoleaksmight
be treated with overstenting, coil embolization or
thrombin injection, if sealing is incomplete or local
disease will progress.30
The anchoring of the stentgraft may prove prob-
lematic in endovascular treatment when it is deployed
in a diseased segment. A fresh PAU at the proximal
stentgraft developed in one case reported by Murgo
et al.31 Czermak et al.32 reported lesions of the aortic
wall proximal and distal to the end of the stentgraft
after endoluminal therapy of PAU. Re-operation in
these two cases was necessary. Since the aorta must
be regarded as very vulnerable in this condition, it
also appears inappropriate to used bare metal stents.
The creation of new entries by bare springs of the
stentgraft appears conceivable.
The perioperative mortality rate in emergency en-
dovascular treatment of thoracic aortic aneurysms is
between 12% and 18%.29,33,34 In the present series,
the perioperative and postoperative mortality was
0%. Of course, this result must be interpreted with
caution, since it derived from only 12 patients. The
appended published series (Table 3) from 116 pa-
tients with PAU worldwide who underwent endo-
vascular treatment shows a postoperative hospitalmortality of 4.5% and a mortality during follow-up
of 9.7%.
In 4 patients, a significant fall was found in both the
systolic and the diastolic blood pressure of the left up-
per limb. In disorders of blood flow in the left arm, the
left subclavian artery could be revascularized by
a transposition in a second operation. As claudication
after covering the left subclavian is rare in our experi-
ence,12e14,16 no transposition was planed in any pa-
tient and none of the patients developed clinical
signs of ischemia of the upper limb or neurological
complications.
In conclusion, persisting pain is the leading cause
for surgical intervention. Endovascular treatment of
PAU seems to be a low-risk method to control this dis-
ease. In view of the high mortality and morbidity of
open surgical therapy in aortic diseases, endovascular
treatment is the favoured treatment option.
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